MedDataX Logo

Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital

NCT ID: NCT04098133

Last Updated: 2024-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-22

Study Completion Date

2029-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective and prospective study is to investigate the incidence of Carbapenemase-producing bacteria (CPB) at the University Hospital Basel, the time to detection of CPB and to initiation of infection control measures, the risk factors associated with carriage of CPB, type and duration of previously administrated antibiotic medication, antibiotic treatment, as well as to assess the outcomes of the affected patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infections With CPB

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Carbapenemase-producing Klebsiella pneumoniae antibiotic resistancy infections with Carbapenemase-producing Bacteria (CPB) Carbapenemase-producing Bacteria

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

data collection for demographic data

data collection for demographic data (age, gender, hospital admission and discharge date, length of stay, hospitalization prior to current hospital stay (acute care facilities, long-term healthcare centres, nursing homes), discharge destination, outcome, cause of death, travel history, previous exposure to antibiotics and proton pump Inhibitors)

Intervention Type OTHER

data collection for clinical data

data collection for clinical data (comorbidities, Charlson Comorbidity Index, immunosuppressive treatment, date of diagnosis of CPB, days between hospital admission and diagnosis of CPB, type of consecutive infection, indwelling vascular hardware, urinary catheterization, surgical therapies)

Intervention Type OTHER

data collection for treatment data

data collection for treatment data (antibiotic therapy, immunosuppressive therapy, concomitant medication)

Intervention Type OTHER

data collection for microbiological data

data collection for microbiological data (species of CPB, type of sample, date of sample, history of colonization or infection with any antibiotic resistant pathogen)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with detection of carbapenemase-producing bacteria from January 1st , 2008 until December 31st , 2028

Exclusion Criteria

* Patients with documented refusal of subsequent use of their data
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Basel, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Tschudin Sutter, Prof. Dr. MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Division of Infectious Diseases and Hospital Epidemiology

Basel, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sarah Tschudin Sutter, Prof. Dr. MD

Role: CONTACT

Phone: +41 61 328 68 10

Email: [email protected]

Isabelle Vock, Dipl. med

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sarah Tschudin Sutter, PD MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-01548; me19Tschudinsutter

Identifier Type: -

Identifier Source: org_study_id